A successful combination of upadacitinib and guselkumab in refractory psoriasis and psoriatic arthritis: A case report
Monotherapy may not be sufficient for the complete control of the psoriatic disease in selected patients. In refractory patients, combining two drugs with different mechanisms of action may result in improved efficacy. Data regarding the combination of biologics and Janus kinase inhibitors are lacki...
Saved in:
| Main Authors: | Sofia Antolini, Giorgia Scagliosi, Olta Veliaj, Antonio Carletto, Elena Fracassi, Paolo Gisondi |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2025-06-01
|
| Series: | SAGE Open Medical Case Reports |
| Online Access: | https://doi.org/10.1177/2050313X251352160 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Gender differences in psychological features and determinates of quality of life in axial spondyloarthritis and psoriatic arthritis: a cross-sectional study
by: Branko Ristic, et al.
Published: (2025-06-01) -
Multirefractory bullous pemphigoid, psoriasis and psoriatic arthritis successfully treated with guselkumab
by: Francisco José Rodríguez-Cuadrado, et al.
Published: (2024-09-01) -
Successful treatment of generalized pustular psoriasis with guselkumab
by: Martina Part
Published: (2024-12-01) -
The use of guselkumab in psoriatic arthritis: evidence from real clinical practice
by: N. V. Nekrasova, et al.
Published: (2021-12-01) -
Psoriasis and Psoriatic Arthritis in ChildhoodPsoriasis and Psoriatic Arthritis in Childhood
by: Nikolay N. Murashkin, et al.
Published: (2020-12-01)